Literature DB >> 23790379

In vitro study of α-synuclein protofibrils by cryo-EM suggests a Cu(2+)-dependent aggregation pathway.

Hangyu Zhang1, Amy Griggs, Jean-Christophe Rochet, Lia A Stanciu.   

Abstract

The aggregation of α-synuclein is thought to play a role in the death of dopamine neurons in Parkinson's disease (PD). Alpha-synuclein transitions itself through an aggregation pathway consisting of pathogenic species referred to as protofibrils (or oligomer), which ultimately convert to mature fibrils. The structural heterogeneity and instability of protofibrils has significantly impeded advance related to the understanding of their structural characteristics and the amyloid aggregation mystery. Here, we report, to our knowledge for the first time, on α-synuclein protofibril structural characteristics with cryo-electron microscopy. Statistical analysis of annular protofibrils revealed a constant wall thickness as a common feature. The visualization of the assembly steps enabled us to propose a novel, to our knowledge, mechanisms for α-synuclein aggregation involving ring-opening and protofibril-protofibril interaction events. The ion channel-like protofibrils and their membrane permeability have also been found in other amyloid diseases, suggesting a common molecular mechanism of pathological aggregation. Our direct visualization of the aggregation pathway of α-synuclein opens up fresh opportunities to advance the understanding of protein aggregation mechanisms relevant to many amyloid diseases. In turn, this information would enable the development of additional therapeutic strategies aimed at suppressing toxic protofibrils of amyloid proteins involved in neurological disorders.
Copyright © 2013 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23790379      PMCID: PMC3686339          DOI: 10.1016/j.bpj.2013.04.050

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  37 in total

1.  Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?

Authors:  M S Goldberg; P T Lansbury
Journal:  Nat Cell Biol       Date:  2000-07       Impact factor: 28.824

2.  Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Authors:  Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

3.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.

Authors:  K A Conway; S J Lee; J C Rochet; T T Ding; R E Williamson; P T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

4.  Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.

Authors:  H Lin; R Bhatia; R Lal
Journal:  FASEB J       Date:  2001-11       Impact factor: 5.191

5.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

6.  Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes.

Authors:  Tomas T Ding; Seung-Jae Lee; Jean-Christophe Rochet; Peter T Lansbury
Journal:  Biochemistry       Date:  2002-08-13       Impact factor: 3.162

7.  Neurodegenerative disease: amyloid pores from pathogenic mutations.

Authors:  Hilal A Lashuel; Dean Hartley; Benjamin M Petre; Thomas Walz; Peter T Lansbury
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

8.  Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.

Authors:  Hilal A Lashuel; Benjamin M Petre; Joseph Wall; Martha Simon; Richard J Nowak; Thomas Walz; Peter T Lansbury
Journal:  J Mol Biol       Date:  2002-10-04       Impact factor: 5.469

9.  The fold of alpha-synuclein fibrils.

Authors:  Marçal Vilar; Hui-Ting Chou; Thorsten Lührs; Samir K Maji; Dominique Riek-Loher; Rene Verel; Gerard Manning; Henning Stahlberg; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-12       Impact factor: 11.205

10.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.

Authors:  Monica Bucciantini; Elisa Giannoni; Fabrizio Chiti; Fabiana Baroni; Lucia Formigli; Jesús Zurdo; Niccolò Taddei; Giampietro Ramponi; Christopher M Dobson; Massimo Stefani
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

View more
  17 in total

1.  Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity.

Authors:  Daniel Ysselstein; Mehul Joshi; Vartika Mishra; Amy M Griggs; Josephat M Asiago; George P McCabe; Lia A Stanciu; Carol Beth Post; Jean-Christophe Rochet
Journal:  Neurobiol Dis       Date:  2015-04-27       Impact factor: 5.996

2.  Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions.

Authors:  Igor F Tsigelny; Yuriy Sharikov; Valentina L Kouznetsova; Jerry P Greenberg; Wolf Wrasidlo; Cassia Overk; Tania Gonzalez; Margarita Trejo; Brian Spencer; Kori Kosberg; Eliezer Masliah
Journal:  ACS Chem Neurosci       Date:  2015-01-21       Impact factor: 4.418

3.  Histones facilitate α-synuclein aggregation during neuronal apoptosis.

Authors:  Peizhou Jiang; Ming Gan; Shu-Hui Yen; Pamela J McLean; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2016-12-21       Impact factor: 17.088

4.  Rational design of charged peptides that self-assemble into robust nanofibers as immune-functional scaffolds.

Authors:  Hangyu Zhang; Jaehyung Park; Yonghou Jiang; Kim A Woodrow
Journal:  Acta Biomater       Date:  2017-03-30       Impact factor: 8.947

5.  Cu(II) promotes amyloid pore formation.

Authors:  Hangyu Zhang; Jean-Christophe Rochet; Lia A Stanciu
Journal:  Biochem Biophys Res Commun       Date:  2015-06-28       Impact factor: 3.575

6.  Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation.

Authors:  Dharmin Rokad; Shivani Ghaisas; Dilshan S Harischandra; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Brain Res Bull       Date:  2016-12-16       Impact factor: 4.077

7.  The H50Q mutation enhances α-synuclein aggregation, secretion, and toxicity.

Authors:  Ossama Khalaf; Bruno Fauvet; Abid Oueslati; Igor Dikiy; Anne-Laure Mahul-Mellier; Francesco Simone Ruggeri; Martial K Mbefo; Filip Vercruysse; Giovanni Dietler; Seung-Jae Lee; David Eliezer; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

8.  Expression and Transport of α-Synuclein at the Blood-Cerebrospinal Fluid Barrier and Effects of Manganese Exposure.

Authors:  Christopher A Bates; Sherleen Fu; Daniel Ysselstein; Jean-Christophe Rochet; Wei Zheng
Journal:  ADMET DMPK       Date:  2015-03-31

9.  α-Synuclein Amyloid Fibrils with Two Entwined, Asymmetrically Associated Protofibrils.

Authors:  Altaira D Dearborn; Joseph S Wall; Naiqian Cheng; J Bernard Heymann; Andrey V Kajava; Jobin Varkey; Ralf Langen; Alasdair C Steven
Journal:  J Biol Chem       Date:  2015-12-07       Impact factor: 5.157

10.  Cu and Zn coordination to amyloid peptides: From fascinating chemistry to debated pathological relevance.

Authors:  Elena Atrián-Blasco; Paulina Gonzalez; Alice Santoro; Bruno Alies; Peter Faller; Christelle Hureau
Journal:  Coord Chem Rev       Date:  2018-09-15       Impact factor: 22.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.